OH Consultant
← Healthcare

WHS Management for Pharmacy Compounding

Control cytotoxic drug exposure, hazardous substance handling, and cleanroom safety in compounding pharmacy operations.

Pharmacy compounding exposes workers to hazardous drugs including cytotoxic agents that cause cancer, reproductive harm, and organ toxicity through dermal absorption, inhalation, and accidental ingestion. Compounding pharmacists and technicians handle concentrated drug powders and solutions in quantities and forms that create exposure pathways not present in standard dispensing operations. Cytotoxic drug compounding requires biological safety cabinets, closed-system transfer devices, and specific PPE that many community compounding pharmacies do not have in place. The new Healthcare Code of Practice commencing February 2026 addresses medication handling hazards and will become binding under Section 26A from 1 July 2026.

Key Hazards

Cytotoxic drug exposure during compounding causing cancer and reproductive harmHazardous drug powder inhalation during weighing and mixingDermal absorption of concentrated drug solutions through inadequate glove protectionMusculoskeletal strain from sustained standing and repetitive compounding tasksChemical exposure to compounding excipients and solventsNeedlestick and sharps injuries during reconstitution and transfer

Regulatory Requirements

HRCW Categories

Work involving hazardous chemicals (cytotoxic drugs), work involving biological hazards

Section 26A Codes (binding 1 July 2026)
Healthcare Code of Practice 2026Managing Risks of Hazardous Chemicals in the WorkplaceHazardous Manual Tasks

SWMS Required

Related Sectors

Need Help with Compounding Pharmacy WHS?

We help compounding pharmacies develop compliant WHS systems covering cytotoxic drug handling, cleanroom safety, and hazardous substance controls.

Contact Us